Siemens Healthineers : Strong rapid antigen test sales led to positive surprise in Q1
>Q1 3% to 8% above consensus, our forecast on key parameters - The company reported revenues of €5.07bn in Q1, 3% above consensus (Vara) and 4% above our forecast. Comparable sales growth was at 9.5% y/y vs our forecast of 5.4% and consensus of 5.8%. While Imaging and Advanced Therapies came broadly in-line with expectations (comparable sales growth of 5.9% and 3.3% y/y, respectively), we are positively surprised by Varian (€750m in revenues in the quarter vs €711m ou...Siemens Healthineers AG is a Germany-based company that supplies technology to the healthcare industry. The Company offers a wide range of products and services in the fields of diagnostic and therapeutic imaging, laboratory and point of care diagnostics, and molecular medicine. It provides medical technology and software solutions, as well as clinical consulting services. Additionally, the Company is developing its digital health and enterprise services trough expanding precision medicine, transforming care delivery, improving patient experience, and digitalizing healthcare to enable healthcare providers to increase value. Siemens AG is a majority shareholder of the Company. The Company is active worldwide.
Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.